| 9.25 Delayed Data As of 4:00pm ET |  +0.22 / +2.44%Today’s Change | 3.90 Today|||52-Week Range 12.53 | +86.49% Year-to-Date |
| Previous close | 9.03 |
| Today’s open | 8.85 |
| Day’s range | 8.75 - 9.48 |
| Volume | 41,257,355 |
| Average volume (3 months) | 25,103,333 |
| Market cap | $9.1B |
| Earnings growth (last year) | +635.53% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +219.06% |
| P/E ratio | NM |
| Price/Sales | 76.68 |
| Price/Book | 4.33 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | -1.73 | -1.38% |
| CRONCronos Group Inc | +1.30 | +6.76% |
| APHAAphria Inc | +0.13 | +1.36% |
| USNAUSANA Health Science... | +0.74 | +0.86% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $43.5M |
| Annual profit (last year) | $56.6M |
| Net profit margin | 130.33% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Terry Booth |
President & Director Steve Dobler |
Corporate headquarters Edmonton, Alberta |
